v3.26.1
Description of Business and Organization (Tables)
12 Months Ended
Dec. 31, 2025
Description of Business and Organization [Line Items]  
Schedule of Consolidated VIE and Subsidiaries of the VIE

As of December 31, 2025, the details of the Company’s major subsidiaries, consolidated VIE and the subsidiaries of the VIE are as follows:

 

   Date of  Place of  Percentage of ownership
by the Company
   
Entity  incorporation  incorporation  Direct  Indirect  Principal activities
Subsidiaries:               
Pom (HK)  March 12, 2021  Hong Kong  100% owned by the Company    Investment holding
Guangzhou WFOE  April 6, 2021  PRC  100% owned by Pom (HK)    WFOE, Investment holding
                
VIE:               
Qilekang Digital Health  January 12, 2010  PRC    94.86%  Online hospital service and pharmaceutical supply chain
                
VIE’s subsidiaries:               
Guangzhou Qilekang Modern Pharmaceutical Logistics Co., Ltd. (“Modern Logistics”)  October 24, 2002  PRC    100% owned by Qilekang Digital Health  Drugs wholesale
Hangzhou Qilekang Pharmaceutical Co., Ltd. (“Hangzhou Qilekang”)  July 27, 2016  PRC    100% owned by Qilekang Digital Health  Offline retail pharmacy and drugs wholesale
Nanjing Qilekang Pharmaceutical Co., Ltd. (“Nanjing Qilekang”)  November 13, 2018  PRC    80% owned by Qilekang Digital Health  Drugs sales
Suzhou Qilekang Pharmaceutical Co., Ltd. (“Suzhou Qilekang”)  September 2, 2024  PRC    100% owned by Qilekang Digital Health  Drugs sales
Guangzhou Qilekang Cloud Technology Co., Ltd. (“Guangzhou Cloud Tech”)  November 5, 2024  PRC    100% owned by Qilekang Digital Health  Online service and pharmaceutical supply chain
Guangzhou Pomegranate Cloud Pharma Health Industry Technology Co., Ltd.  February 20, 2025  PRC    100% owned by Qilekang Cloud Technology  Drugs sales
Guangzhou Wanggang International Medical Management Co., Ltd.  September 26, 2017  PRC    100% owned by Qilekang Cloud Technology  Drugs sales
Schedule of Financial Information for the VIE

The following tables represent the selected financial information for the VIE as of December 31, 2024 and 2025 and for the years ended December 31, 2023, 2024 and 2025.

 

   December 31,
2024
   December 31,
2025
   December 31,
2025
 
   RMB   RMB   US$ 
Current assets   37,880,384    46,138,392    6,597,704 
Non-current assets   8,730,173    2,590,800    370,480 
Total assets   46,610,557    48,729,192    6,968,184 
Current liabilities   179,145,271    264,182,042    37,777,533 
Non-current liabilities   366,763,077    370,685,951    53,007,385 
Total liabilities   545,908,348    634,867,993    90,784,918 
Net deficit   (499,297,791)   (586,138,801)   (83,816,734)

 

   For the Years Ended December 31, 
   2023   2024   2025   2025 
   RMB   RMB   RMB   US$ 
Net revenues   304,852,971    342,557,920    399,914,964    57,187,079 
Net loss   (36,949,421)   (37,365,434)   (130,931,921)   (18,723,015)

 

   For the Years Ended December 31, 
   2023   2024   2025   2025 
   RMB   RMB   RMB   US$ 
Net cash used in operating activities   (45,831,182)   (16,155,582)   (11,414,010)   (1,632,182)
Net cash used in investing activities   (111,891)   (33,373)   (1,607,753)   (229,906)
Net cash provided by financing activities   50,067,178    17,016,080    13,870,644    1,983,476